Nothing Special   »   [go: up one dir, main page]

AR032248A1 - Preparacion para mejorar la asimilacion de los alimentos - Google Patents

Preparacion para mejorar la asimilacion de los alimentos

Info

Publication number
AR032248A1
AR032248A1 ARP020100155A ARP020100155A AR032248A1 AR 032248 A1 AR032248 A1 AR 032248A1 AR P020100155 A ARP020100155 A AR P020100155A AR P020100155 A ARP020100155 A AR P020100155A AR 032248 A1 AR032248 A1 AR 032248A1
Authority
AR
Argentina
Prior art keywords
preparation
improve food
assimilation
food
preparations
Prior art date
Application number
ARP020100155A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of AR032248A1 publication Critical patent/AR032248A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)

Abstract

La presente invencion se refiere a preparaciones para sustancias alimenticias y medicamentos que contienen ácido octadecatrienoico trans/cis conjugado, así como al procedimiento para su preparacion. La invencion se refiere, además a la utilizacion de las preparaciones para reducir la ingestion de los alimentos en el ser humano y los animales, y para una mejor asimilacion de los alimentos.
ARP020100155A 2001-01-17 2002-01-17 Preparacion para mejorar la asimilacion de los alimentos AR032248A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10102050A DE10102050A1 (de) 2001-01-17 2001-01-17 Zubereitung zur Verbesserung der Nahrungsverwertung

Publications (1)

Publication Number Publication Date
AR032248A1 true AR032248A1 (es) 2003-10-29

Family

ID=7670919

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100155A AR032248A1 (es) 2001-01-17 2002-01-17 Preparacion para mejorar la asimilacion de los alimentos

Country Status (7)

Country Link
US (1) US7304089B2 (es)
EP (1) EP1353569A2 (es)
JP (2) JP2004520036A (es)
AR (1) AR032248A1 (es)
CA (1) CA2435077A1 (es)
DE (1) DE10102050A1 (es)
WO (1) WO2002056708A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10158046A1 (de) * 2001-11-27 2003-06-05 Basf Ag Formulierung für den Einsatz in Lebensmitteln, Nahrungsergänzungsmitteln, Futtermitteln, Futterzusatzstoffen, pharmazeutischen und kosmetischen Zubereitungen sowie Verfahren zu deren Herstellung
WO2005063230A1 (en) * 2003-12-30 2005-07-14 Universite Laval Use of conjugated linolenic acids for reducing body fat mass
JP2005264077A (ja) * 2004-03-19 2005-09-29 Nisshin Oillio Group Ltd 共役型トリエン酸含有油脂組成物及びその油脂の製造方法
JP4772295B2 (ja) * 2004-06-22 2011-09-14 学校法人順天堂 共役脂肪酸を有効成分とする運動能力改善剤
US8377482B2 (en) * 2004-09-09 2013-02-19 Warburton Technology Limited Trace elements
CN101098690A (zh) * 2004-12-06 2008-01-02 瑞莱恩特医药品有限公司 用于血脂治疗的ω-3脂肪酸和脂血异常剂
GB0514463D0 (en) * 2005-01-31 2005-08-17 Loders Croklaan Bv Use of pinolenic acid
AU2006242463A1 (en) * 2005-04-29 2006-11-09 Hill's Pet Nutrition, Inc. Methods for prolonging feline life
EP2034983A1 (en) * 2006-06-27 2009-03-18 Lipid Nutrition B.V. Use of a polyunsaturated fatty acid compound
GB0814105D0 (en) * 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
EP2498617B1 (en) * 2009-11-10 2014-06-18 Cognis IP Management GmbH A composition comprising a lipid suitable for human consumption
MX348659B (es) * 2010-11-19 2017-05-08 Centro De Innovacion Biotecnologica A C Alimentos funcionales con altos contenidos de harina de soya (sbm), almidon y bacillus ssp.
US20120178813A1 (en) 2011-01-12 2012-07-12 Thetis Pharmaceuticals Llc Lipid-lowering antidiabetic agent
US9382187B2 (en) 2012-07-10 2016-07-05 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US8765811B2 (en) 2012-07-10 2014-07-01 Thetis Pharmaceuticals Llc Tri-salt form of metformin
CA2947741A1 (en) 2014-05-05 2015-11-12 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
US9242008B2 (en) 2014-06-18 2016-01-26 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of fatty acids
US9999626B2 (en) 2014-06-18 2018-06-19 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of active agents
WO2016094615A1 (en) * 2014-12-11 2016-06-16 The Penn State Research Foundation Medical food for the treatment of malaria and/or iron deficiency
ES2827796T3 (es) 2016-06-03 2021-05-24 Thetis Pharmaceuticals Llc Composiciones y procedimientos relativos a sales de mediadores pro-resolutivos especializados de inflamación
CN115462456B (zh) * 2022-08-19 2024-03-15 金金 一种冬季用肉羊中草药饲料添加剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE303998B (es) 1959-12-02 1968-09-16 Brinckmann Harburger Fett
DE1156789B (de) 1960-04-16 1963-11-07 Brinckmann Harburger Fett Verfahren zur Umwandlung von Fettsaeureestern einwertiger Alkohole mit isolierten Doppelbindungen (íÀIsolenfettsaeureesterníÂ) in Fettsaeureester mit konjugierten Doppelbindungen (íÀKonjuenfettsaeureesteríÂ)
DE1156788C2 (de) 1959-12-02 1973-11-22 Brinckmann Harburger Fett Verfahren zur Umwandlung von Fettsaeureestern einwertiger Alkohole mit isolierten Doppelbindungen (íÀIsolenfettsaeureesterníÂ) in Fettsaeureester mit konjugierten Doppelbindungen (íÀKonjuenfettsaeureesteríÂ)
GB921688A (en) 1960-09-15 1963-03-20 Nippon Storage Battery Mfg Com Improvements in and relating to plates for lead-acid batteries
US3356694A (en) * 1964-08-20 1967-12-05 Syntex Corp 3-keto-4-methylene derivatives of the androstane and pregnane series and process therefor
US3356699A (en) * 1965-06-09 1967-12-05 Marvin O Bagby Alkali isomerization of crepenynic acid to 8, 10, 12-octadecatrienoic acid
US5428072A (en) 1992-04-29 1995-06-27 Wisconsin Alumni Research Foundation Method of increasing the efficiency of feed conversion in animals
US5554646A (en) 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
US5814663A (en) 1994-08-29 1998-09-29 Wisconsin Alumni Research Foundation Method for maintaining an existing level of body fat
US5760082C1 (en) 1994-08-29 2001-03-06 Wisconsin Alumni Res Found Dietetic foods containing conjugated linoleic acids
US5665386A (en) * 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5585400A (en) 1996-02-27 1996-12-17 Wisconsin Alumni Research Foundation Methods of attenuating the allergic response in animals
DE19638729B4 (de) * 1996-09-13 2004-09-23 Lancaster Group Gmbh Stabile Mehrphasenemulsion vom Typ 01/W/O2, Verfahren zu ihrer Herstellung sowie ihre Verwendung
JP3017108B2 (ja) 1996-10-30 2000-03-06 リノール油脂株式会社 共役リノール酸の製造方法
JP2001525364A (ja) 1997-12-12 2001-12-11 パーデュー・リサーチ・ファンデーション 糖尿病を治療する方法及び組成物
US6197305B1 (en) * 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity
CA2339871A1 (en) 1998-08-20 2000-03-02 Abbott Laboratories Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
EP1105486B1 (en) * 1998-08-20 2011-04-27 E.I. Du Pont De Nemours And Company Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation
DE60028368T2 (de) * 1999-04-15 2007-02-01 Kaneka Corp. Agonisten des peroxisom aktivator-responsiven rezeptors
JP3207824B2 (ja) * 1999-05-28 2001-09-10 リノール油脂株式会社 共役リノレン酸を有効成分とする乳癌抑制剤
US6444238B1 (en) * 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
AU2001264161A1 (en) * 2000-05-09 2001-11-20 Bioriginal Food And Science Corp. Production of conjugated linoleic and linolenic acids in plants

Also Published As

Publication number Publication date
WO2002056708A3 (de) 2002-11-07
DE10102050A1 (de) 2002-07-18
JP2004520036A (ja) 2004-07-08
US7304089B2 (en) 2007-12-04
CA2435077A1 (en) 2002-07-25
JP2009132721A (ja) 2009-06-18
EP1353569A2 (de) 2003-10-22
US20040047894A1 (en) 2004-03-11
WO2002056708A2 (de) 2002-07-25

Similar Documents

Publication Publication Date Title
AR032248A1 (es) Preparacion para mejorar la asimilacion de los alimentos
ATE304368T1 (de) Kräuterpflanzen enthaltende artzneimittel
DK1179984T3 (da) Metode til fremstilling af en sammensætning til forbedring af immunforsvaret hos kæledyr under anvendelse af en kombination af antioxidanter
HN1999000124A (es) Derivados de pirazol substituido.
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
IL192137A (en) Formulations useful in the treatment of male and female impotence
UY26139A1 (es) Composiciones de medicamentos a base de compuestos anticolinérgicamente activos y beta- miméticos
HN2002000152A (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco
AR032977A1 (es) Composiciones coprocesadas utiles como espesantes culinarios
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
CR9363A (es) Composiciones para la transmision transmucosa oral de la metformina
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
CR8240A (es) Hidrolizado de colageno
ATE223955T1 (de) Traubenkerne, kaltgepresstes traubenkernöl, traubenkernschrot und traubenkernmehl
DE602004016403D1 (de) Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
CR9079A (es) Nonadepsipeptidos acilados como derivados de lisobactina
UY28115A1 (es) Derivados del acido isoftalico
CR7166A (es) Microcapsulas para la proteccion frente al mal aliento
GT200200249A (es) Composicion herbicida
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
HN1998000141A (es) Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientom para fabricarla.
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
EP1491192A4 (en) COMPOSITIONS STRENGTHENING BIOLOGICAL ACTIVITY THAT CONTAIN AN ISOFLAVONE AGLYCONE FROM SOYBEAN GERMS

Legal Events

Date Code Title Description
FG Grant, registration